Singapore, Feb. 27 -- Florricks Lifecare, a leading research-driven pharmaceutical company in India, involved in R&D, production, and sales of Active Pharmaceutical Ingredients (API) and Finished Dosage Forms across multiple therapeutic areas, including critical care and oncology, has entered into strategic partnerships with two prominent companies in Hong Kong and Europe, marking a total investment of $95 million.

The partnerships aim to leverage Florricks Lifecare's expertise in cutting-edge pharmaceutical solutions, bolstering its presence and capabilities in these critical regions.

Dr Salim Shaikh, Managing Director & CEO of Florricks Lifecarestated,"With this significant investment, the company is set to make substantial strides in...